Stages of Lyme Disease and Their Respective Treatments
Lyme disease progresses through three distinct stages: early localized, early disseminated, and late disseminated, each requiring specific antibiotic treatments based on clinical manifestations and disease severity.
Stage I: Early Localized Infection (Days to Weeks)
Clinical Manifestations:
- Erythema migrans (EM): Pathognomonic gradually expanding annular lesion >5 cm in diameter at the tick bite site 1
- Associated symptoms: Fever, lymphadenopathy, myalgias, arthralgias 1
- Occurs in approximately 70-80% of infected persons 1
Diagnosis:
- Clinical diagnosis based on EM rash in endemic areas (no laboratory testing needed) 1
- Serologic testing has low sensitivity (30-40%) during this early stage 1
Treatment:
- Oral antibiotics for 10-14 days 2:
- Doxycycline: 100 mg twice daily (first-line for adults and children ≥8 years)
- Amoxicillin: 500 mg three times daily (preferred for children <8 years, pregnant women)
- Cefuroxime axetil: 500 mg twice daily (alternative)
- Azithromycin (second-line option)
Stage II: Early Disseminated Infection (Weeks to Months)
Clinical Manifestations:
- Multiple EM lesions (hematogenous spread) 1
- Borrelial lymphocytoma (bluish-red tumor-like skin infiltrate, often on ear lobe or nipple) 1
- Neurologic involvement:
- Facial nerve palsy (Bell's palsy)
- Meningitis
- Meningoradiculitis 1
- Cardiac involvement (5% of cases):
Diagnosis:
- Two-tiered serologic testing: ELISA/IFA followed by Western immunoblot 1, 2
- Sensitivity of 70-100% during this stage 1
- Specificity >95% 1
Treatment:
For neurologic manifestations:
For cardiac manifestations:
Stage III: Late Disseminated Infection (Months to Years)
Clinical Manifestations:
- Arthritis: Recurrent large-joint arthritis, especially knee 1
- Acrodermatitis chronica atrophicans (ACA): Bluish-red discoloration progressing to skin atrophy, associated with B. afzelii 1
- Late neurologic manifestations (uncommon in US):
- Peripheral neuropathy
- Encephalopathy
- Encephalomyelitis 1
Diagnosis:
- Strong serologic reactivity with expanded Western blot IgG banding patterns 1
- Synovial fluid analysis in arthritis cases shows mild-to-moderate inflammation 1
- PCR of synovial fluid may provide additional diagnostic certainty in seropositive patients 1
Treatment:
For arthritis:
For late neurologic manifestations:
- IV antibiotics (ceftriaxone, cefotaxime, or penicillin G) for 14-21 days 2
Important Clinical Considerations:
- Antibody persistence: Antibodies often persist for months or years after successfully treated infection, so seroreactivity alone cannot be used as a marker of active disease 1
- Post-Lyme disease syndrome: Some patients experience persistent symptoms after appropriate treatment that are not responsive to additional antibiotics 1, 2
- The IDSA, AAN, and ACR do not recognize "chronic Lyme disease" as a valid diagnosis and recommend against prolonged antibiotic therapy 2
- Geographic variations: B. burgdorferi sensu stricto predominates in the US, while B. afzelii and B. garinii are more common in Europe and Asia, affecting clinical manifestations 1, 3
Prophylaxis:
For high-risk tick bites meeting all criteria:
- Identified Ixodes tick attached for ≥36 hours
- Prophylaxis started within 72 hours of tick removal
- Local infection rate of ticks with B. burgdorferi ≥20%
- Single dose of doxycycline: 200 mg for adults, 4.4 mg/kg (max 200 mg) for children ≥8 years 2
Proper early diagnosis and appropriate antibiotic treatment are essential to prevent progression to later stages of Lyme disease and their associated complications.